Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. Onderneming
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
Beroep
Logo GlaxoSmithKline plc
GlaxoSmithkline plc is de tweede grootste farmaceutische groep ter wereld. De netto-omzet is als volgt verdeeld over de verschillende productfamilies:

- farmaceutische producten (50%): bestemd voor aandoeningen van de luchtwegen (64,9% van de netto-omzet), HIV-infectie (28,6%), aandoeningen van het immuunsysteem (4,3%) ) en kanker (2,2%)

- OTC en parafarmaceutische geneesmiddelen (29,4%)

- vaccins (20,5%)

- andere (0,1%)

De netto-omzet is geografisch als volgt verdeeld: Verenigd Koninkrijk (2,9%), Verenigde Staten (42,7%) en overige (54,4%).

Aantal werknemers : 94 066 mensen.
Verkoop per activiteit
20192020Delta
Pharmaceuticals17 554.0052%17 056.0050% -2.84%
Consumer Healthcare8 995.0026.6%10 033.0029.4% +11.54%
Vaccines7 157.0021.2%6 982.0020.5% -2.45%
Corporate and Other Unallocated48.000.1%28.000.1% -41.67%
GBP in miljoenen
Verkoop per regio
20192020Delta
United States13 890.0041.2%14 556.0042.7% +4.79%
Rest of World11 795.0034.9%11 379.0033.4% -3.53%
Europe7 127.0021.1%7 184.0021.1% +0.8%
United Kingdom942.002.8%980.002.9% +4.03%
GBP in miljoenen
Managers
Naam Titel Leeftijd Van
Emma Walmsley Chief Executive Officer & Executive Director 51 2017
Iain Mackay Chief Financial Officer & Executive Director 59 2019
Karenann Terrell Chief Digital & Technology Officer 58 2017
Hal Barron Executive Director & Chief Scientific Officer 57 2018
Jon Ellis VP & Head-Technology Business Development 53 2019
Amy Altshul SVP-Legal, Research & Development - -
Romulo Colindres VP-Global Medical Affairs Lead for Zoster 49 -
Lynn Laverty Elsenhans Independent Non-Executive Director 63 2012
Urs Rohner Independent Non-Executive Director 61 2015
Manvinder Singh Banga Senior Independent Non-Executive Director 65 2016
Bestuurders
Naam Titel Leeftijd Van
Jonathan Symonds Non-Executive Chairman 61 2019
Emma Walmsley Chief Executive Officer & Executive Director 51 2017
Lynn Laverty Elsenhans Independent Non-Executive Director 63 2012
Urs Rohner Independent Non-Executive Director 61 2015
Manvinder Singh Banga Senior Independent Non-Executive Director 65 2016
Jesse L. Goodman, Dr. Independent Non-Executive Director 68 2016
Vivienne Cox Independent Non-Executive Director 61 2016
Laurie H. Glimcher, Dr. Independent Non-Executive Director 68 2017
Hal Barron Executive Director & Chief Scientific Officer 57 2018
Iain Mackay Chief Financial Officer & Executive Director 59 2019
Aandelen
Stemming AantalPercentage vrij verhandelbaarBedrijfseigen aandelenDrijvend Totaal
Aandeel A 1 5 386 937 397 4 968 070 912 92.2% 355 205 950 6.6% 92.2%
Aandeelhouders
NaamAandelen%
The Vanguard Group, Inc. 151 654 522 3,01%
BlackRock Fund Advisors 131 211 690 2,61%
Norges Bank Investment Management 117 972 000 2,34%
Dodge & Cox 99 377 874 1,98%
Capital Research & Management Co. (Global Investors) 81 077 927 1,61%
BlackRock Advisors (UK) Ltd. 69 356 000 1,38%
Schroder Investment Management Ltd. 67 445 105 1,34%
State Street Global Advisors Ltd. 66 345 263 1,32%
Threadneedle Asset Management Ltd. 57 003 962 1,13%
Silchester International Investors LLP 56 966 000 1,13%
Belangnemingen
NaamAandelen%Totale waarde
LYELL IMMUNOPHARMA, INC. (LYEL) 30 253 189 12,6% 477 697 854 USD
VIR BIOTECHNOLOGY, INC. (VIR) 6 626 027 5,07% 341 505 432 USD
GLAXOSMITHKLINE CONSUMER HEALTHCARE PAKISTAN LIMITED (GSKCH) 100 423 259 85,8% 165 681 305 USD
GLAXOSMITHKLINE S.A.E (BIOC) 76 161 378 91,2% 151 788 865 USD
THERAVANCE BIOPHARMA, INC. (TBPH) 9 644 807 13,1% 80 051 898 USD
BICYCLE THERAPEUTICS LIMITED 1 529 561 7,18% 54 605 328 USD
FULCRUM THERAPEUTICS, INC. (FULC) 1 785 714 4,43% 53 035 706 USD
DONG-A SOCIO HOLDINGS CO., LTD. (A000640) 409 693 6,45% 40 635 384 USD
SPERO THERAPEUTICS, INC. (SPRO) 1 740 606 5,41% 33 506 666 USD
ALLERGY THERAPEUTICS PLC (AGY) 10 118 000 1,58% 4 609 154 USD
Markten en indices
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Beurscodes
- Bloomberg-code :  GSK:LN
- Reuters Code :  GSK.L
- Datastreamcode :  GSK
Bedrijfsgegevens
GlaxoSmithKline plc
980 Great West Road
TW8 9GS Brentford, Greater London

Telefoon : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Merk portefeuille
In samenwerking metMijn merken op de beurs
Meer merken vanGlaxoSmithKline plc
Sector Farmaceutische producten - Andere
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
GLAXOSMITHKLINE PLC3.44%95 560
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604
ABBVIE INC.0.54%190 378
NOVARTIS AG-7.42%186 081
MERCK & CO., INC.-12.37%181 449
ASTRAZENECA PLC10.09%171 794
BRISTOL-MYERS SQUIBB COMPANY-1.16%136 238
AMGEN INC.-4.58%124 575
SANOFI3.62%120 158
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%62 799
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 566
BAYER AG-6.12%52 137
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 910
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%46 272
ASTELLAS PHARMA INC.18.51%31 855
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY49.98%24 783